“[T]his Valentine’s Day, perhaps it’s time to celebrate with a gift many of the world’s women desperately want and need: reproductive health,” Robert Engelman, president of the Worldwatch Institute, writes in this Huffington Post “Global Motherhood” opinion piece. Engelman provides global maternal mortality statistics and notes, “Access to family planning and other reproductive health services safeguard the lives of women and their children and promote families that are emotionally and economically healthy.”
“While the headlines out of the World Economic Forum (WEF) meetings in Davos primarily focus on getting (or keeping) the global economy on track, it’s a welcome development when nutrition and health information also rise to the top of the priorities list, reminding world leaders of the inextricable link between nutrition, health and well-being of the people on our planet and that of our global economy,” Klaus Kraemer, director of Sight and Life, a not-for-profit nutrition think tank, writes in GlobalPost’s “Global Pulse” blog.
In this Huffington Post opinion piece, Leslie Gerwin, associate director of law and public affairs at Princeton University, reflects on the recent controversy over whether to research and publish data about potentially dangerous strains of the H5N1 bird flu virus, writing, “I am disturbed that so much coverage of this dispute — so deserving of sober consideration — is fixated on fear mongering.” She notes, “Those opposing research or publication … predict that publishing results will lead to abuse or misuse by terrorists looking to create a biological weapon. … Those favoring continuation of the project warn of ‘censorship,’ a constitutional no-no particularly when involving the ‘suppression’ of science.”
The announcement at the end of January of the largest coordinated effort to fight neglected tropical diseases (NTDs) provides “more reason to hope that we may soon see a future free of these diseases,” Adetokunbo Lucas, former director of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, writes in a Daily Monitor opinion piece. “This new coordinated action will take these previous efforts to a whole new level,” he writes, adding, “Together, these partners have pledged to increase the supply of existing drugs and invest and collaborate on research to accelerate the development of new and better drugs.”
“Current negotiations on a free trade agreement (FTA) between the European Union and India are causing serious concern in many quarters over future access to cheap generic medicines used to treat some of the world’s great public health threats: HIV, tuberculosis and malaria, and also cancer,” Philippe Douste-Blazy, U.N. special adviser on innovative financing for development and chair of UNITAID, and Denis Broun, executive director of UNITAID, write in this post in the Guardian’s “Poverty Matters Blog.” “Those fears are well founded: if the E.U. and India agree on stringent patent and border measures, India’s role as the ‘pharmacy of the south’ could well come to an end,” they add.
Noting the successes of the first 10 years of the Global Fund to Fight AIDS, Tuberculosis and Malaria, as well as the funding challenges it faces moving forward, Elisha Dunn-Georgiou, vice president of advocacy at Population Action International, writes in an opinion piece in GlobalPost’s “Global Pulse” blog that the Fund “has always upheld the idea that their work contributes to achievement of all of the health-related Millennium Development Goals (MDGs)” and “always accepted and considered proposals that include reproductive, maternal, and child health interventions, when countries could demonstrate that they would have an impact on AIDS, tuberculosis, and malaria.”
In this post in the ONE blog, Brooks Keene, policy adviser for CARE’s water team, “makes the argument that foreign aid should benefit the poor first and foremost,” noting, “As we approach World Water Day on March 22, CARE, [the Natural Resources Defense Council (NRDC)] and WaterAid have published a report card [.pdf] on how well” the Water for the Poor Act, passed by Congress in 2005, “has been implemented seven years down the line.” She writes, “In the absence of a strategy, USAID has gone ahead with water, sanitation and hygiene programs, but much of the effort and dollars have not gone to benefit the poor.” She concludes by recommending several steps USAID could take “to spur concerted targeting” (2/9).
“Amidst pro-democracy protests, the Russian authorities have taken what is an ongoing assault on HIV prevention to the next level by moving to silence public health advocates whose only infraction has been to spread lifesaving information online and to criticize the government for its own failures,” Eka Iakobishvili, a human rights analyst at Harm Reduction International, and Claudia Stoicescu, an analyst on Harm Reduction International’s public health research team, write in this Huffington Post opinion piece. “While Prime Minister Putin spoke glowingly of digital democracy” in a recent column praising the potential for “internet-based democracy,” “his anti-drugs agency is censoring websites for writing about WHO essential medicine,” the authors note.
Applauding the signing of the so-called “London Declaration on NTDs” by a consortium of public and private partners last week, Ned Breslin, CEO of Water For People, writes in this Huffington Post “Impact” opinion piece, “I am saddened by the emphasis on vaccines and medicines as the seemingly only vehicles to eradicate NTDs by London Declaration signatories. And I wonder where water, sanitation and hygiene are in this mix, as by all accounts it is not anywhere to be seen in the NTD eradication initiative.”
While a focus on HIV prevention and treatment among women and children has reduced infection rates among these populations, “men have received considerably less attention in the epidemic and receive less targeted HIV prevention and treatment programs,” Edward Mills of the University of Ottawa and colleagues write in a PLoS Medicine essay, adding “Targeting men in prevention and treatment … may have a large impact on mortality, new infections, and the economic impact of HIV/AIDS in Africa.” They note that in Africa, fewer men than women access antiretroviral therapy (ART), and men “typically have higher mortality,” seek care later in the disease, and “are more likely to be lost to follow-up.”